Guided Therapeutics (GTHP) Gross Profit (2016 - 2025)
Historic Gross Profit for Guided Therapeutics (GTHP) over the last 16 years, with Q3 2025 value amounting to $35000.0.
- Guided Therapeutics' Gross Profit changed N/A to $35000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $112000.0, marking a year-over-year increase of 46000.0%. This contributed to the annual value of $2000.0 for FY2024, which is 9444.44% down from last year.
- Latest data reveals that Guided Therapeutics reported Gross Profit of $35000.0 as of Q3 2025.
- Guided Therapeutics' 5-year Gross Profit high stood at $79000.0 for Q2 2025, and its period low was -$79000.0 during Q4 2022.
- Moreover, its 5-year median value for Gross Profit was $4000.0 (2022), whereas its average is $6933.3.
- In the last 5 years, Guided Therapeutics' Gross Profit plummeted by 29268.29% in 2022 and then skyrocketed by 22500.0% in 2023.
- Guided Therapeutics' Gross Profit (Quarter) stood at $41000.0 in 2021, then tumbled by 292.68% to -$79000.0 in 2022, then soared by 120.25% to $16000.0 in 2023, then tumbled by 112.5% to -$2000.0 in 2024, then surged by 1850.0% to $35000.0 in 2025.
- Its Gross Profit stands at $35000.0 for Q3 2025, versus $79000.0 for Q2 2025 and -$2000.0 for Q4 2024.